Decay of androgen receptor immunoreactivity in archived tissue by using monoclonal antibody F39.4.1

Applied Immunohistochemistry

Volumn 6, Issue 3, 1998, Pages 145-149

  Dash, Rajesh C ^a,b   Ballo, Michael S ^b   Layfield, Lester J ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

Androgen receptor; F39.4.1; Formalin fixed; Paraffin embedded; Prostate adenocarcinoma; Receptor decay

Indexed keywords

ANDROGEN RECEPTOR; AVIDIN; BIOTIN; FORMALDEHYDE; IMMUNOGLOBULIN KAPPA CHAIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY F39 4 1; PARAFFIN; PEROXIDASE; UNCLASSIFIED DRUG;

ANALYZER; ARTICLE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOREACTIVITY; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA;

EID: 0031682951     PISSN: 10623345     EISSN: None     Source Type: Journal    
DOI: 10.1097/00022744-199809000-00007     Document Type: Article

References (14)

1. DeMascarel I, Soubcyrani I, MacGrogan G, et al. Immunohistochemical assay of estrogen receptors in 938 breast carcinomas: concordance with biochemical assay and prognostic significance. Appl Immunohlstochem 1995;3:222-31.
2. Layfield LJ, Saria EA, Conlon DH, Kerns BJM. Estrogen and progesterone receptor status determined by the Ventana ES320 automated immunohistochemical stainer and CAS 200 image analyzer in 236 early stage breast carcinomas: prognostic significance. J Surg Oncol 1996;61:177-84.
3. Kimura N, Mizokami A, Oonuma T, Sasano H, Nagura H. Immunocytochemical localization of androgen receptor with polyclonal antibody, in paraffin-embedded human tissues. J Histochem Cytocliem 1993;41:671-8.
4. Ruizeveld de Winter JA, Trapman J, Vcrmey M, Mulder E, Zegers ND, Van Der Kwast TH. Androgen receptor expression in human tissues: an immunohistochemical study. J Histochem Cytochem 1991:39:927-36.
5. Janssen PJ, Brinkmann AO, Boersma WJ, Van Der Kwast TH. Immunohistochemical detection of the androgen receptor with monoclonal antibody F39.4 in routinely processed, paraffinembedded human tissues after microwave pretreatment. J Histochem Cytochem 1994;42:1169-75.
6. Ekman P, Snochowski M, Zetterberg A, Hogberg B, Gustafsson JA. Steroid receptor content in human prostatic carcinoma and response to endocrine therapy. Cancer 1979;44:1173-81.
7. Trachtenberg J, Walsh PC. Correlation of prostatic nuclear androgen receptor content with duration of response and survival following hormonal therapy in advanced prostatic cancer. J Urol 1982;127:466-71.
8. Sidh SM, Young JD Jr, Karmi SA, Powder JR, Bashirelahi N. Adenocarcinoma of prostate: role of 17 β-estradiol and 5 - αdihydrotestosterone binding proteins. Urology 1979;13:597-603.
9. Jasper WS, Abou-Issa H, Gogate SA, Snider CB. Steroid hormone receptors and endocrine response of prostatic carcinoma. Cancer Detect Prevent 1987; 10:393-9.
10. Osborne CK, Yochmowitz MG, Knight WA, McGuire WL. The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 1980;46:2884-8.
11. Wittliff JL. Steroid-hormone receptors in breast cancer. Cancer 1984;53:630-43.
12. Prioleau J, Schnitt SJ. p53 antigen loss in stored paraffin slides. W Engl J Med 1995;332:1521-2.
13. Jacobs T, Proilean J, Stillman I, Schnitt S. Loss of tumor marker immunostaining intensity of stored paraffin slides of breast cancer [Abstract]. Mod Palhol 1996;9:18A.
14. Shin HJC, Kalapurakal SK, Lee JJ, Ro JY, Hons WK, Lee JS. Comparison of p53 immunoreactivity in fresh-cut versus stored slides with and without microwave heating. Mod Pathol 1997; 10:224-30.